跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,527 条关于
“MTS-128”
全部
8,527
临床试验
6,295
药物
1,172
机构
44
资讯
1,016
2个月前
METiS TechBio Licenses AI-Designed Trispecific T-Cell Engager MTS-128 to Boulevard Bio in Deal Worth Up to $1.6 Billion
11个月前
METiS TechBio's AI-Designed Drug MTS-004 Becomes First in China to Complete Phase III Trial for Pseudobulbar Affect
9个月前
METiS TechBio Advances mRNA Cancer Therapeutics with Dual Publications in Nature Communications and JITC
6个月前
METiS TechBio Debuts on Hong Kong Exchange as World's First Publicly Listed AI-Powered Drug Delivery Company
11个月前
Neurona Therapeutics Receives EMA PRIME Designation for NRTX-1001 Cell Therapy in Drug-Resistant Focal Epilepsy
去年
Eravacycline Shows Sustained Antimicrobial Activity Against Resistant Bacteria in vitro
21天前
BioXcel Therapeutics Files Chapter 11, Lines Up $125M Teva Stalking-Horse Asset Sale
去年
FDA Accepts NDA for LENZ Therapeutics' LNZ100 for Presbyopia Treatment
去年
Lenz Therapeutics' LNZ100 Receives FDA Acceptance for Presbyopia Treatment
2年前
Kymera's KT-333 Demonstrates Antitumor Activity in Hematological Cancers in Phase 1 Trial
第 1 页,共 102 页
上一页
下一页